Janux Historical Financial Ratios
| JANX Stock | USD 48.82 1.49 2.96% |
Janux Therapeutics is lately reporting on over 92 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 1.44 or Days Sales Outstanding of 0.0 will help investors to properly organize and evaluate Janux Therapeutics financial condition quickly.
Janux |
About Janux Financial Ratios Analysis
Janux TherapeuticsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Janux Therapeutics investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Janux financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Janux Therapeutics history.
Janux Therapeutics Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Janux Therapeutics stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Janux Therapeutics sales, a figure that is much harder to manipulate than other Janux Therapeutics multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Payables Turnover
A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.Capex To Revenue
The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.Most ratios from Janux Therapeutics' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Janux Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Janux Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Janux Stock please use our How to Invest in Janux Therapeutics guide.At this time, Janux Therapeutics' Price Book Value Ratio is fairly stable compared to the past year. Ebt Per Ebit is likely to rise to 1.14 in 2024, despite the fact that Free Cash Flow Yield is likely to grow to (0.11).
| 2022 | 2023 | 2024 (projected) | Interest Debt Per Share | 0.71 | 0.56 | 0.59 | Revenue Per Share | 0.21 | 0.18 | 0.13 |
Janux Therapeutics fundamentals Correlations
Click cells to compare fundamentals
Janux Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Janux Stock Analysis
When running Janux Therapeutics' price analysis, check to measure Janux Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Janux Therapeutics is operating at the current time. Most of Janux Therapeutics' value examination focuses on studying past and present price action to predict the probability of Janux Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Janux Therapeutics' price. Additionally, you may evaluate how the addition of Janux Therapeutics to your portfolios can decrease your overall portfolio volatility.